CLL: Chromosomal abnormalities (FISH) and their relation with clinical stage, CD38 and ZAP-70

Revista Brasileira de Hematologia e Hemoterapia

Volumn 28, Issue 1, 2006, Pages 5-10

  Nascimento, Marilia C ^b   Yamamoto, Mioko ^b   Rodrigues, Maria Madalena ^b   Franco, Luciana F ^b   Kimura, Elisa Y S ^b   Vasconcelos, Yuri ^b   Oliveira, José S R ^b   Figueiredo, Vera L P ^b   Chauffaille, Maria De Lourdes L F ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b NONE

Author keywords

Chronic lymphocytic leukemia; Cytogenetics; FISH

Indexed keywords

EID: 33747376048     PISSN: 15168484     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1516-84842006000100004     Document Type: Article

References (40)

1. Catovsky D, Fooks J, Richards S. Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. British Journal of Haematology 1989;72:141-149.
2. Dighiero G, Maloum K, Desablens B et al. Chlorambucil in indolent chronic lymphocytic leukemia: French Cooperative Group on Chronic Lymphocytic Leukemia. New England Journal of Medicine 1998;338:1.506-1.514.
3. Rozman C, Montserrat E. Current concepts: chronic lymphocytic leukemia. New England Journal of Medicine 1995; 333:1.052-1.057.
4. Döhner H, Stilgenbauer S, Benner A et al. Genomic aberrations and survival in chronic lymphocytic leukemia. New England Journal of Medicine 2000; 343:1.910-1.916.
5. Zwiebel JA, Cheson BD. Chronic lymphocytic leukemia: Staging and prognostic factors. Seminars in Oncology 1998;25:42-59.
6. Rai KR, Sawitsky A, Cronkite EP et al. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-234.
7. Binet JL, Auquier A, Dighiero G et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198-206.
8. Damle RN, Wasil T, Fais F et al. IgV gene status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94:1.840-1.847.
9. Ibrahim S, Keating M, Do KA et al. CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia. Blood 2001;98:181-186.
10. Hamblin TJ, Orchard JA, Ibbotson RE et al. CD38 expressions and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease. Blood 2002; 99:1.023-1.029.
11. Bosch F, Crespo M, Villamor N et al. ZAP-70 expression has a prominent position among prognostic factors in chronic lymphocytic leukemia (CLL): Results of a multivariate analysis in 192 patients. Blood 2003 (abstr.) 102 (S):665.
12. Wiestner A, Rosenwald A, Barry T et al. ZAP70 expression identifies B-CLL with unmutated immunoglobulin genes, worse clinical outcome and a distinct gene expression profile. Blood 2002 (abstr.) 100 (S):168.
13. Orchard JA, Ibbotson RE, Davis ZA et al. ZAP-70 evaluation by flow cytometry is a significant prognostic marker in B-CLL. Blood 2002 (abstr.) 100 (S):168.
14. H sequencing in CLL. Blood 2003 (abstr.) 102 (S):346.
15. Juliusson G, Merup M. Cytogenetics in chronic lymphocytic leukemia. Seminars in Oncology 1998;25:19-26.
16. nd ed. Marcel Dekker Inc 2001. New York, 353-376.
17. Mould S, Gardiner A, Corcoran M et al. Trisomy 12 and structural abnormalities of 13q14 occurring in the same clone in chronic lymphocytic leukemia. British Journal of Haematology 1996;92:389-392.
18. Hjalmar V, Hast R, Kimby E. Sequential fluorescence in situ hybridization analyses for trisomy 12 in chronic leukemic B-cell disorders. Haematologica 2001;86:174-180.
19. Matutes E, Oscier D, Garcia-Marco J et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. British Journal of Haematology 1996; 92:382-388.
20. Rai KR, Döhner H, Keating MJ et al. Chronic lymphocytic leukemia: Case-Based Session. Hematology 2001;140-156.
21. Amiel A, Arbov L, Manor Y, et al. Monoallelic p53 deletion in chronic lymphocytic leukemia detected by interphase cytogenetics. Cancer Genetics and Cytogenetics 1997; 97:97-100.
22. Hallek M, Hallek KI, Emmerich B. Prognostic factors in chronic lymphocytic leukemia. Leukemia 1997;2 (11 suppl):4-13.
23. Chauffaille MLLF, Vieira S, Martins SLR. Importância do cariótipo em leucemia linfocítica crônica: relato de 18 casos. Jornal Brasileiro de Patologia e Medicina Laboratorial 2004;40:75-78.
24. Que TH, Garcia-Marco J, Ellis J et al. Trisomy 12 in chronic lymphocytic leukemia detected by FISH: Analysis by stage, immunophenotype, and morphology. Blood 1993;82:571-575.
25. Lazaridou A, Miraxtsi C, Korantzis J et al. Simultaneous detection of BCL-2 protein, trisomy 12, retinoblastoma and p53 monoallelic gene delections in B-cell chronic lymphocytic leukemia by FISH: Relation to disease status. Leukemia and Lymphoma 2000;36:503-512.
26. Eclache V, Caulet-Maugendre S, Poirel HA et al. Cryptic deletion involving the ATM locus at 11q22.3-q23.1 in B-cell chronic leukemia and related disorders. Cancer Genetics and Cytogenetics 2004;152:72-76.
27. Starostik P, Manshouri T, O'Brian S et al. Deficiency of the ATM protein expression defines an aggressive subgroup of B-Cell chronic lymphocytic leukemia. Cancer Research 1998;58:4.552-4.557.
28. Neilson JR, Auer R, White D et al. Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival. Leukemia 1997;11:1.929-1.932.
29. Döhner H, Stilgenbauer S, Döhner K et al. Chromosome aberrations in B-cell chronic leukemia: reassessment based on molecular cytogenetic analysis. Journal of Molecular Medicine 1999;77:266-281.
30. Giles FJ, Bekele BN, O'Brien S et al. A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression. British Journal of Haematology 2003;121:578-585.
31. Callet-Bauchu E, Salles G, Gazzo S et al. Translocations involving the short arm of chromosome 17 in chronic B-lymphoid disorders: frequent occurrence of dicentric rearrangements and possible association with adverse outcome. Leukemia 1999;13:460-468.
32. Garcia-Marco JA, Price CM, Catovsky D. Interphase cytogenetics in chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics 1997;94:52-58.
33. Catovsky D, Fooks J, Richards S. Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex and response to treatment in survival. British Journal of Haematology 1989;72:141-149.
34. Bosch F, Montserrat E. Refining prognostic factors in chronic lymphocytic leukemia. Reviews in Clinical and Experimental Hematology 2002;6:335-349.
35. Del Poeta G, Maurillo L, Venditti A et al. Clinical significance of CD38 expression in chronic lymphocytic leukemia. Blood 2001;98:2.633-2.639.
36. Abbasi SY, Mavromatis BH, Ozdemirli M et al. Correlation of CD38 expression and cytogenetic abnormalities in chronic lymphocytic leukemia (CLL). Blood 2003 (abstr.);102 (S): 350.
37. Dewald GW, Brockman SR, Paternoster SF et al. Chromosome anomalies detected by interphase fluorescence in situ hybridization: correlation with significant biological features of B-cell chronic lymphocytic leukemia. British Journal of Haematology 2003;121:287-95.
38. Pittner BT, Tschumper RC, Kimlinger TK et al. Expression of ZAP-70 in both unmutated and mutated leukemic CLL B cells indicates lack of efficacy as a surrogate marker for immunoglobulin mutational status. Blood 2003 (abstr.);102 (S):34.
39. Grever MR, Dewald GW, Lucas DM et al. ZAP-70 protein expression varies by interphase cytogenetic group and may predict disease progression to requirement of treatment among select genetic groups in patients with chronic lymphocytic leukemia (CLL). Blood 2003 (abstr.);102 (S):73
40. Stilgenbauer S, Bullinger L, Lichter P et al. Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical course. Leukemia 2002;16:993-1.007.